isosorbide dinitrate has been researched along with Left Ventricular Hypertrophy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akers, S; Beraun, M; Chirinos, JA; Chittams, J; Haines, PG; Koppula, MR; Rawat, D; Segers, P; Shiva-Kumar, P; Soto-Calderon, H; Townsend, RR; Varakantam, S; Witschey, WR; Zamani, P | 1 |
| Leslie, SJ; Megson, IL | 1 |
| Li, H; Wang, S | 1 |
| Endo, H; Hirao, H; Kobayashi, M; Kutsuna, H; Shimamura, S; Shimizu, M; Tanaka, R; Yamane, Y | 1 |
| Paulis, L; Simko, F | 1 |
| Delgado, C; Fernández-Velasco, M; Mourelle, M; Ruiz-Hurtado, G | 1 |
| Blinston, GE; Jugdutt, BI; Jugdutt, SJ; Khan, MI | 1 |
| Jugdutt, BI; Khan, MI | 1 |
| Cohn, JN; Francis, GS; Hunter, D; Matthews, J; McDonald, KM | 1 |
| Antony, I; Nitenberg, A | 1 |
| Keteyian, SJ; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
| Karppanen, H; Laakso, J; Mervaala, E; Teräväinen, TL; Vapaatalo, H; Vaskonen, T | 1 |
1 review(s) available for isosorbide dinitrate and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders.
Topics: Animals; Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Disease Models, Animal; Drug Tolerance; Fibrinolytic Agents; Humans; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Myocardial Ischemia; Nitric Oxide Donors; Patents as Topic; Structure-Activity Relationship; Treatment Outcome | 2009 |
3 trial(s) available for isosorbide dinitrate and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Female; Fibrosis; Heart Failure; Heart Ventricles; Humans; Hydralazine; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Pilot Projects; Stroke Volume; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Organic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.
Topics: Adult; Aged; Antihypertensive Agents; Arginine; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |
Epicardial coronary arteries are not adequately sized in hypertensive patients.
Topics: Blood Flow Velocity; Cardiac Catheterization; Coronary Angiography; Coronary Circulation; Coronary Vessels; Echocardiography; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Least-Squares Analysis; Statistics, Nonparametric; Vasodilator Agents; Ventricular Function, Left | 1996 |
8 other study(ies) available for isosorbide dinitrate and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Effect of intermittent administration of sustained release isosorbide dinitrate (sr-ISDN) in rats with pressure-overload heart.
Topics: Administration, Oral; Animals; Aorta, Abdominal; Body Weight; Delayed-Action Preparations; Disease Models, Animal; Endomyocardial Fibrosis; Histocytochemistry; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocytes, Cardiac; Nitric Oxide Donors; Organ Size; Rats; Rats, Wistar | 2006 |
LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling.
Topics: Animals; Blood Pressure; Humans; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Ventricular Remodeling | 2007 |
LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation.
Topics: Animals; Blood Pressure; Caveolin 3; Cyclic GMP; Fibrosis; HSP90 Heat-Shock Proteins; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2007 |
Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen.
Topics: Animals; Captopril; Collagen; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction.
Topics: Animals; Dogs; Echocardiography; Female; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocardial Infarction; Myocardium; Nitroglycerin; Time Factors; Ventricular Function, Left | 1994 |
Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog.
Topics: Administration, Oral; Animals; Dogs; Electric Injuries; Hemodynamics; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Myocardial Infarction; Time Factors | 1993 |
Reverse remodeling in heart failure with intensification of vasodilator therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Middle Aged; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1997 |
Cardiovascular effects of dietary salts and isosorbide-5-mononitrate in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cations; Condiments; Delayed-Action Preparations; Heart Rate; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Kidney; Male; Mesenteric Arteries; Rats; Rats, Inbred SHR; Salts; Sodium, Dietary; Vasodilator Agents | 1998 |